Search results

ANSTO shared expertise on next-generation reactors and nuclear power with sustainable energy experts at the Australian Academy of Science symposium in May.

An international team led by scientists at City University of Hong Kong has found flexible metal-organic framework (MOF) with one-dimensional channels that acts as a “molecular trapdoor” to selectively adsorb gases, such as carbon dioxide, in response to temperature and pressure changes.

Highlighting the contribution of four inspirational ANSTO leaders on International Women's Day.

The Japanese experience with leading-edge radiation treatment for cancer shows tremndous success

Lithium Australia, a company that has a close association with ANSTO’s business unit Minerals, has been awarded a US patent for its unique lithium mining technology SiLeach®.

The most important data from NASA’s first crewed Artemis mission may not be its photographs, but the radiation measurements that will shape how humans work and survive beyond travel farther from Earth’s magnetic shelter safely.

ANSTO’s Innovation Precinct welcomes NSW Government’s $12.5 commitment funding.

Australia’s new Mo-99 manufacturing facility reaches practical completion

Nuclear science is crucial to understanding our universe, our world and ourselves at the atomic level. If we can understand how atoms get together, interact, or can be best combined with other atoms, new, more efficient materials and drugs can be developed.

Imaging protocol assesses molecular mechanism of work in the treatment of deadly childhood cancer neuroblastoma.

Research will change understanding of Australian Aboriginal rock art found in rock shelters of the Kimberley and its relationship to a changing landscape

The OPAL research reactor's design and integrated safety features mean it is extremely safe; a fact confirmed by independent analysis.

The nuclear analysis team at ANSTO recently had a significant role in the re-design and optimisation of a cold neutron source facility for the reactor, its installation and the subsequent restart after a six-month shutdown.

Radioactive phosphorous for implantable medical device to treat pancreatic cancer in global clinical trial